{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T21:02:44Z","timestamp":1777064564865,"version":"3.51.4"},"update-to":[{"DOI":"10.1002\/14651858.cd011108","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T00:00:00Z","timestamp":1476144000000}}],"reference-count":59,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011108.pub2","type":"journal-article","created":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T16:25:18Z","timestamp":1476375918000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Hydromorphone for cancer pain"],"prefix":"10.1002","author":[{"given":"Yan J","family":"Bao","sequence":"first","affiliation":[{"name":"Guang'anmen Hospital, China Academy of Chinese Medical Sciences; Department of Oncology; Beixiange 5 Beijing Xicheng District China 100053"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Hou","sequence":"additional","affiliation":[{"name":"Guang'anmen Hospital, China Academy of Chinese Medical Sciences; Department of Oncology; Beixiange 5 Beijing Xicheng District China 100053"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang Y","family":"Kong","sequence":"additional","affiliation":[{"name":"China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica; Nanxiaojie, Dongzhimennei Ave Beijing China 100700"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Yang","sequence":"additional","affiliation":[{"name":"Guang'anmen Hospital, China Academy of Chinese Medical Sciences; Department of Nephrology; Beixiange 5 Beijing Xicheng District China 100053"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Xia","sequence":"additional","affiliation":[{"name":"Systematic Review Solutions Ltd; 89 Russell Drive Nottingham UK 264000"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao J","family":"Hua","sequence":"additional","affiliation":[{"name":"Guang'anmen Hospital, China Academy of Chinese Medical Sciences; Department of Oncology; Beixiange 5 Beijing Xicheng District China 100053"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Knaggs","sequence":"additional","affiliation":[{"name":"University of Nottingham; School of Pharmacy; University Park Nottingham UK NG7 2RD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,10,11]]},"reference":[{"key":"10.1002\/14651858.CD011108.pub2-BIB0001|cit1","doi-asserted-by":"crossref","unstructured":"Hagen NA Babul N Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain Cancer 1997 1428 37","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1428::AID-CNCR21>3.0.CO;2-0"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1472-684X-7-17","article-title":"A randomized, double-blind comparison of OROS(R) hydromorphone and controlled-release morphine for the control of chronic cancer pain","volume":"7","author":"Hanna","year":"2008","journal-title":"BMC palliative care"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0003|cit3","unstructured":"NCT00410540 A study of OROS hydromorphone HCl vs morphine in cancer pain patients clinicaltrials.gov\/ct2\/show\/NCT00410540"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0004|cit4","unstructured":"Moriarty M McDonald CJ Miller AJ A randomised crossover comparison of controlled release hydromorphone tablets with controlled release morphine tablets in patients with cancer pain Journal of Clinical Research 1999 1 8"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0005|cit5","unstructured":"NCT01205126 An efficacy and safety study of oral osmotic therapeutic system (OROS) hydromorphone hydrochloride (HCl) in participants with cancer related pain clinicaltrials.gov\/ct2\/show\/NCT01205126"},{"issue":"8","key":"10.1002\/14651858.CD011108.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jpain.2014.04.008","article-title":"Safety and efficacy of once-daily hydromorphone extended-release versus twice-daily oxycodone hydrochloride controlled-release in Chinese patients with cancer pain: a phase 3, randomized, double-blind, multicenter study","volume":"15","author":"Yu","year":"2014","journal-title":"Journal of Pain : official journal of the American Pain Society"},{"issue":"3","key":"10.1002\/14651858.CD011108.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00520-013-2030-1","article-title":"A prospective, open-label, multicenter study of the clinical efficacy of extended-release hydromorphone in treating cancer pain inadequately controlled by other analgesics","volume":"22","author":"Han","year":"2014","journal-title":"Supportive Care in Cancer : official journal of the Multinational Association of Supportive Care in Cancer"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0008|cit8","doi-asserted-by":"crossref","unstructured":"Lee KH Kim MK Hyun MS Kim JY Park KU Song HS Clinical effectiveness and safety of OROS hydromorphone in breakthrough cancer pain treatment: a multicenter, prospective, open-label study in Korean patients Journal of Opioid Management 2012 243 52","DOI":"10.5055\/jom.2012.0122"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0009|cit9","doi-asserted-by":"crossref","unstructured":"Wirz S Wartenberg HC Nadstawek J Less nausea, emesis, and constipation comparing hydromorphone and morphine? A prospective open-labeled investigation on cancer pain Support Care Cancer 2008 999 1009","DOI":"10.1007\/s00520-007-0368-y"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0010|cit10","doi-asserted-by":"crossref","unstructured":"Wirz S Wittmann M Schenk M Schroeck A Schaefer N Mueller M Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine European Journal of Pain 2009 737 43","DOI":"10.1016\/j.ejpain.2008.09.005"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0011|cit11","unstructured":"NCT02084355 Study of opioid rotation versus opioid escalation in patients with moderate to severe cancer pain clinicaltrials.gov\/ct2\/show\/NCT02084355"},{"issue":"10","key":"10.1002\/14651858.CD011108.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/pon.1122","article-title":"Associated and predictive factors of sleep disturbance in advanced cancer patients","volume":"16","author":"Akechi","year":"2007","journal-title":"Psycho-oncology"},{"issue":"9","key":"10.1002\/14651858.CD011108.pub2-BIB0013|cit13","first-page":"697","article-title":"SIAARTI recommendations on the assessment and treatment of chronic cancer pain","volume":"69","author":"Ambrosio","year":"2003","journal-title":"Minerva Anestesiologica"},{"issue":"1","key":"10.1002\/14651858.CD011108.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00000542-200101000-00014","article-title":"Pharmacodynamics of orally administered sustained-release hydromorphone in humans","volume":"94","author":"Angst","year":"2001","journal-title":"Anesthesiology"},{"issue":"14","key":"10.1002\/14651858.CD011108.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2165\/00002018-200225140-00004","article-title":"Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS): a retrospective study","volume":"25","author":"Bass","year":"2002","journal-title":"Drug Safety"},{"issue":"5","key":"10.1002\/14651858.CD011108.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1533-2500.2009.00342.x","article-title":"A randomized study to demonstrate noninferiority of once-daily OROS\u00ae hydromorphone with twice-daily sustained-release oxycodone for moderate to severe chronic noncancer pain","volume":"10","author":"Binsfeld","year":"2010","journal-title":"Pain Practice"},{"issue":"5","key":"10.1002\/14651858.CD011108.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/0269216310392102","article-title":"Is oral morphine still the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative guidelines project","volume":"25","author":"Caraceni","year":"2011","journal-title":"Palliative Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011108.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncology"},{"issue":"3","key":"10.1002\/14651858.CD011108.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"E283","DOI":"10.36076\/ppj.2011\/14\/E283","article-title":"Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain","volume":"14","author":"Deer","year":"2011","journal-title":"Pain Physician"},{"issue":"4","key":"10.1002\/14651858.CD011108.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00000542-200210000-00013","article-title":"Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers","volume":"97","author":"Drover","year":"2002","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1002\/14651858.CD011108.pub2-BIB0021|cit21","first-page":"349","article-title":"Pathogenesis and management of cancer-related insomnia","volume":"3","author":"Graci","year":"2005","journal-title":"Journal of Supportive Oncology"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0022|cit22","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780192632340.001.0001","volume-title":"Oxford Textbook of Clinical Pharmacology and Drug Therapy","author":"Grahame-Smith","year":"2002"},{"issue":"4","key":"10.1002\/14651858.CD011108.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD011108.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.12968\/ijpn.2008.14.1.28150","article-title":"Sleep disturbance in patients with advanced cancer","volume":"14","author":"Hearson","year":"2008","journal-title":"International Journal of Palliative Nursing"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0025|cit25","unstructured":"Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0026|cit26","unstructured":"Merskey H Bogduk N Part III: pain terms, a current list with definitions and notes on usage Classification of Chronic Pain 2nd Edition Seattle, WA IASP Task Force on Taxonomy, IASP Press"},{"issue":"5","key":"10.1002\/14651858.CD011108.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/0269216311406313","article-title":"A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project","volume":"25","author":"King","year":"2011","journal-title":"Palliative Medicine"},{"issue":"5","key":"10.1002\/14651858.CD011108.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1177\/0269216311401948","article-title":"A systematic review of oxycodone in the management of cancer pain","volume":"25","author":"King","year":"2011","journal-title":"Palliative Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011108.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/jpm.2006.9.437","article-title":"Sleep disturbance in supportive care of cancer: a review","volume":"9","author":"Kvale","year":"2006","journal-title":"Journal of Palliative Medicine"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ejca.2008.03.022","article-title":"Management of cancer pain: basic principles and neuropathic cancer pain","volume":"44","author":"Laird","year":"2008","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0031|cit31","volume-title":"Palliative Care: Transforming the Care of Serious Illness","author":"Meier","year":"2010"},{"issue":"5","key":"10.1002\/14651858.CD011108.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00520-004-0623-4","article-title":"Sleep disorders in advanced cancer patients: prevalence and factors associated","volume":"12","author":"Mercadante","year":"2004","journal-title":"Supportive Care in Cancer : official journal of the Multinational Association of Supportive Care in Cancer"},{"issue":"1","key":"10.1002\/14651858.CD011108.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0885-3924(99)00036-6","article-title":"Continuous subcutaneous infusion of morphine vs. hydromorphone: a controlled trial","volume":"18","author":"Miller","year":"1999","journal-title":"Journal of Pain and Symptom Management"},{"issue":"7","key":"10.1002\/14651858.CD011108.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"12","key":"10.1002\/14651858.CD011108.pub2-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008242.pub2","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011108.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"issue":"5","key":"10.1002\/14651858.CD011108.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpainsymman.2005.01.007","article-title":"Hydromorphone","volume":"29","author":"Murray","year":"2005","journal-title":"Journal of Pain and Symptom Management"},{"issue":"6","key":"10.1002\/14651858.CD011108.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jpainsymman.2011.12.280","article-title":"Safety and tolerability of once-daily OROS(\u00ae) hydromorphone extended-release in opioid-tolerant adults with moderate-to-severe chronic cancer and noncancer pain: pooled analysis of 11 clinical studies","volume":"44","author":"Nalamachu","year":"2012","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"c3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD011108.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0885-3924(02)00390-1","article-title":"Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain","volume":"23","author":"Palangio","year":"2002","journal-title":"Journal of Pain and Symptom management"},{"issue":"5","key":"10.1002\/14651858.CD011108.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/0269216310387962","article-title":"The role of hydromorphone in cancer pain treatment: a systematic review","volume":"25","author":"Pigni","year":"2011","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(99)01310-0","article-title":"Management of cancer pain","volume":"353","author":"Portenoy","year":"1999","journal-title":"Lancet"},{"issue":"9784","key":"10.1002\/14651858.CD011108.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/S0140-6736(11)60236-5","article-title":"Treatment of cancer pain","volume":"377","author":"Portenoy","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD011108.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0885-3924(02)00643-7","article-title":"A systematic review of hydromorphone in acute and chronic pain","volume":"25","author":"Quigley","year":"2003","journal-title":"Journal of Pain and Symptom Management"},{"issue":"3","key":"10.1002\/14651858.CD011108.pub2-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004847.pub2","article-title":"Opioid switching to improve pain relief and drug tolerability","author":"Quigley","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0046|cit46","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 2014"},{"issue":"4","key":"10.1002\/14651858.CD011108.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1188\/11.CJON.374-379","article-title":"Oncology pain and complementary therapy","volume":"15","author":"Running","year":"2011","journal-title":"Clinical Journal of Oncology Nursing"},{"issue":"2","key":"10.1002\/14651858.CD011108.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s005200000183","article-title":"Hydromorphone: pharmacology and clinical applications in cancer patients","volume":"9","author":"Sarhill","year":"2001","journal-title":"Support Care Cancer"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6904-7-2","article-title":"Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence and absence of food","volume":"7","author":"Sathyan","year":"2007","journal-title":"BMC Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD011108.pub2-BIB0050|cit50","first-page":"1","article-title":"Opioid guidelines in the management of chronic non-cancer pain","volume":"9","author":"Trescot","year":"2006","journal-title":"Pain Physician"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0051|cit51","first-page":"279","volume-title":"Pain Relief in Advanced Cancer","author":"Twycross","year":"1994"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00000542-198809000-00029","article-title":"Patient controlled analgesia: a comparison of intravenous versus subcutaneous hydromorphone","volume":"69","author":"Urquhart","year":"1988","journal-title":"Anesthesiology"},{"issue":"9","key":"10.1002\/14651858.CD011108.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","article-title":"Prevalence of pain in patients with cancer: a systematic review of the past 40 years","volume":"18","author":"Beuken-van Everdingen","year":"2007","journal-title":"Annals of Oncology"},{"issue":"1-3","key":"10.1002\/14651858.CD011108.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0168-3659(01)00550-8","article-title":"Formulation aspects in the development of osmotically controlled oral drug delivery systems","volume":"79","author":"Verma","year":"2002","journal-title":"Journal of Controlled Release : official journal of the Controlled Release Society"},{"key":"10.1002\/14651858.CD011108.pub2-BIB0055|cit55","volume-title":"Cancer Pain Relief","author":"World Health Organization","year":"1986"},{"issue":"7","key":"10.1002\/14651858.CD011108.pub2-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003868.pub3","article-title":"Oral morphine for cancer pain","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD011108.pub2-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011056.pub2","article-title":"Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain","author":"Wiffen","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3-4","key":"10.1002\/14651858.CD011108.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3121\/cmr.2008.813","article-title":"Spinal cord stimulation as a treatment option for intractable neuropathic cancer pain","volume":"6","author":"Yakovlev","year":"2008","journal-title":"Clinical Medicine & Research"},{"issue":"10","key":"10.1002\/14651858.CD011108.pub2-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003447.pub2","article-title":"Hydromorphone for acute and chronic pain","author":"Quigley","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd011108.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011108.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T22:40:19Z","timestamp":1718836819000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD011108.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,11]]},"references-count":59,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011108.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD011108.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,11]]}}}